Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 428

1.

Our experience of repeat laparoscopic liver resection in patients with recurrent hepatocellular carcinoma.

Ogawa H, Nakahira S, Inoue M, Irei T, Hasegawa M, Kato K, Oyama K, Himura H, To T, Maki R, Nishi H, Ohara N, Mikami J, Makari Y, Nakata K, Tsujie M, Fujita J.

Surg Endosc. 2019 Jul 18. doi: 10.1007/s00464-019-06992-8. [Epub ahead of print]

PMID:
31321532
2.

[Paraffinoma with Spinal Paralysis 40 Years After Pleural Plombage for Tuberculosis].

Arai W, Ohkawa M, Takahashi Y, Tada M, Maki R, Mishina T, Miyajima M, Watanabe A.

Kyobu Geka. 2019 May;72(5):344-347. Japanese.

PMID:
31268030
3.

Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas.

Dancsok AR, Setsu N, Gao D, Blay JY, Thomas D, Maki RG, Nielsen TO, Demicco EG.

Mod Pathol. 2019 Jul 1. doi: 10.1038/s41379-019-0312-y. [Epub ahead of print]

PMID:
31263176
4.

Outcomes of completion lobectomy long after segmentectomy.

Takahashi Y, Miyajima M, Tada M, Maki R, Mishina T, Watanabe A.

J Cardiothorac Surg. 2019 Jun 26;14(1):116. doi: 10.1186/s13019-019-0941-8.

5.

An unusual case of Kaposi sarcoma masquerading as cystitis in a kidney transplant recipient.

Nair V, Sheikh F, Hirschwerk D, Fahmy A, Bhaskaran M, Grodstein E, Winnick A, Maki R, Teperman L, Molmenti E.

Transpl Infect Dis. 2019 Jun 20:e13132. doi: 10.1111/tid.13132. [Epub ahead of print]

PMID:
31220395
6.

Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma.

Berlow NE, Rikhi R, Geltzeiler M, Abraham J, Svalina MN, Davis LE, Wise E, Mancini M, Noujaim J, Mansoor A, Quist MJ, Matlock KL, Goros MW, Hernandez BS, Doung YC, Thway K, Tsukahara T, Nishio J, Huang ET, Airhart S, Bult CJ, Gandour-Edwards R, Maki RG, Jones RL, Michalek JE, Milovancev M, Ghosh S, Pal R, Keller C.

BMC Cancer. 2019 Jun 17;19(1):593. doi: 10.1186/s12885-019-5681-6.

7.

Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.

Maki RA, Holzer M, Motamedchaboki K, Malle E, Masliah E, Marsche G, Reynolds WF.

Free Radic Biol Med. 2019 Jun 6;141:115-140. doi: 10.1016/j.freeradbiomed.2019.05.033. [Epub ahead of print]

PMID:
31175983
8.

Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.

Patel S, von Mehren M, Reed DR, Kaiser P, Charlson J, Ryan CW, Rushing D, Livingston M, Singh A, Seth R, Forscher C, D'Amato G, Chawla SP, McCarthy S, Wang G, Parekh T, Knoblauch R, Hensley ML, Maki RG, Demetri GD.

Cancer. 2019 Aug 1;125(15):2610-2620. doi: 10.1002/cncr.32117. Epub 2019 Jun 7.

PMID:
31173362
9.

Novel HMGA2-YAP1 fusion gene in aggressive angiomyxoma.

Lee MY, da Silva B, Ramirez DC, Maki RG.

BMJ Case Rep. 2019 May 28;12(5). pii: e227475. doi: 10.1136/bcr-2018-227475.

PMID:
31142482
10.

Successful management of aberrant right hepatic duct during laparoscopic cholecystectomy: a rare case report.

Oyama K, Nakahira S, Ogawa H, Kato K, Hasegawa M, To T, Maki R, Himura H, Nishi H, Ohhara N, Mikami J, Makari Y, Nakata K, Tsujie M, Fujita J.

Surg Case Rep. 2019 May 9;5(1):74. doi: 10.1186/s40792-019-0632-7.

11.

Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study.

Blay JY, Schöffski P, Bauer S, Krarup-Hansen A, Benson C, D'Adamo DR, Jia Y, Maki RG.

Br J Cancer. 2019 May;120(11):1026-1032. doi: 10.1038/s41416-019-0462-1. Epub 2019 May 8.

PMID:
31065111
12.

A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas.

Jones RL, Chawla SP, Attia S, Schöffski P, Gelderblom H, Chmielowski B, Le Cesne A, Van Tine BA, Trent JC, Patel S, Wagner AJ, Chugh R, Heyburn JW, Weil SC, Wang W, Viele K, Maki RG.

Cancer. 2019 Jul 15;125(14):2445-2454. doi: 10.1002/cncr.32084. Epub 2019 Apr 29.

13.

Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.

Davis LE, Bolejack V, Ryan CW, Ganjoo KN, Loggers ET, Chawla S, Agulnik M, Livingston MB, Reed D, Keedy V, Rushing D, Okuno S, Reinke DK, Riedel RF, Attia S, Mascarenhas L, Maki RG.

J Clin Oncol. 2019 Jun 1;37(16):1424-1431. doi: 10.1200/JCO.18.02374. Epub 2019 Apr 23.

PMID:
31013172
14.

[Surgical Treatment for Pneumopyothorax Secondary to Pancreatic Fistula].

Ohkawa M, Arai W, Takahashi Y, Maki R, Tada M, Mishina T, Miyajima M, Watanabe A.

Kyobu Geka. 2019 Mar;72(3):209-212. Japanese.

PMID:
30923298
15.

[Improvement of Pain Control after Dealing with Chemical Coping-A Case of Local Recurrence of Rectal Cancer].

Nishi H, Ohtake Y, Toh T, Himura H, Maki R, Mikami J, Kishimoto T, Ogawa H, Nakahira S, Makari Y, Nakata K, Tsujie M, Fujita J, Ohzato H.

Gan To Kagaku Ryoho. 2018 Dec;45(13):2342-2344. Japanese.

PMID:
30692458
16.

An IRAK1-PIN1 signalling axis drives intrinsic tumour resistance to radiation therapy.

Liu PH, Shah RB, Li Y, Arora A, Ung PM, Raman R, Gorbatenko A, Kozono S, Zhou XZ, Brechin V, Barbaro JM, Thompson R, White RM, Aguirre-Ghiso JA, Heymach JV, Lu KP, Silva JM, Panageas KS, Schlessinger A, Maki RG, Skinner HD, de Stanchina E, Sidi S.

Nat Cell Biol. 2019 Feb;21(2):203-213. doi: 10.1038/s41556-018-0260-7. Epub 2019 Jan 21.

17.

Sorafenib for Advanced and Refractory Desmoid Tumors.

Gounder MM, Mahoney MR, Van Tine BA, Ravi V, Attia S, Deshpande HA, Gupta AA, Milhem MM, Conry RM, Movva S, Pishvaian MJ, Riedel RF, Sabagh T, Tap WD, Horvat N, Basch E, Schwartz LH, Maki RG, Agaram NP, Lefkowitz RA, Mazaheri Y, Yamashita R, Wright JJ, Dueck AC, Schwartz GK.

N Engl J Med. 2018 Dec 20;379(25):2417-2428. doi: 10.1056/NEJMoa1805052.

18.

Efficacy and Tolerability of 5-Year Adjuvant Imatinib Treatment for Patients With Resected Intermediate- or High-Risk Primary Gastrointestinal Stromal Tumor: The PERSIST-5 Clinical Trial.

Raut CP, Espat NJ, Maki RG, Araujo DM, Trent J, Williams TF, Purkayastha DD, DeMatteo RP.

JAMA Oncol. 2018 Dec 1;4(12):e184060. doi: 10.1001/jamaoncol.2018.4060. Epub 2018 Dec 13.

PMID:
30383140
19.

Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A Review.

Paoluzzi L, Maki RG.

JAMA Oncol. 2019 Feb 1;5(2):254-260. doi: 10.1001/jamaoncol.2018.4490.

PMID:
30347044
20.

Left upper pulmonary vein connected to the persistent left superior vena cava and the left atrium.

Maki R, Miyajima M, Mishina T, Watanabe A.

Gen Thorac Cardiovasc Surg. 2019 Aug;67(8):723-725. doi: 10.1007/s11748-018-1018-7. Epub 2018 Oct 6.

PMID:
30293219
21.

A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors.

D'Adamo DR, Dickson MA, Keohan ML, Carvajal RD, Hensley ML, Hirst CM, Ezeoke MO, Ahn L, Qin LX, Antonescu CR, Lefkowitz RA, Maki RG, Schwartz GK, Tap WD.

Oncologist. 2019 Jun;24(6):857-863. doi: 10.1634/theoncologist.2018-0160. Epub 2018 Aug 20.

PMID:
30126857
22.

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.

Jones RL, Demetri GD, Schuetze SM, Milhem M, Elias A, Van Tine BA, Hamm J, McCarthy S, Wang G, Parekh T, Knoblauch R, Hensley ML, Maki RG, Patel S, von Mehren M.

Ann Oncol. 2018 Sep 1;29(9):1995-2002. doi: 10.1093/annonc/mdy253.

PMID:
30084934
23.

Thoracoscopic Right Basilar Segmentectomy After Right Upper Lobectomy.

Tada M, Miyajima M, Mishina T, Takahashi Y, Maki R, Watanabe A.

Ann Thorac Surg. 2019 Feb;107(2):e123-e125. doi: 10.1016/j.athoracsur.2018.06.041. Epub 2018 Aug 2.

PMID:
30077592
24.

[p40 Negative Basaloid Squamous Cell Carcinoma of the Lung;Report of a Case].

Maki R, Sugita S, Ono Y, Miyajima M, Tada M, Takahashi Y, Mishina T, Watanabe A.

Kyobu Geka. 2018 Jul;71(7):547-550. Japanese.

PMID:
30042259
25.

Laparoscopic resection of retroperitoneal paraganglioma behind the Spiegel lobe in a kyphotic patient: A rare case report.

Ogawa H, Nakahira S, Kishimoto T, Kato K, Hasegawa M, Oyama K, Tou T, Maki R, Himura H, Nishi H, Ohhara N, Mikami J, Makari Y, Nakata K, Tsujie M, Fujita J, Ohzato H.

Asian J Endosc Surg. 2019 Jul;12(3):344-347. doi: 10.1111/ases.12631. Epub 2018 Jul 17.

PMID:
30015378
26.

Thoracoscopic one-stage lobectomy and diaphragmatic plication for T3 lung cancer.

Takahashi Y, Miyajima M, Mishina T, Maki R, Tada M, Tsuruta K, Watanabe A.

J Cardiothorac Surg. 2018 Jul 9;13(1):86. doi: 10.1186/s13019-018-0766-x.

27.

TERT promoter mutations in solitary fibrous tumour.

Demicco EG, Wani K, Ingram D, Wagner M, Maki RG, Rizzo A, Meeker A, Lazar AJ, Wang WL.

Histopathology. 2018 Nov;73(5):843-851. doi: 10.1111/his.13703. Epub 2018 Sep 19.

PMID:
29985536
28.

Before-after, control-impact analysis of evidence for the impacts of water level on Walleye, Northern Pike and Yellow Perch in lakes of the Rainy-Namakan complex (MN, USA and ON, CA).

Larson JH, Maki RP, Vondra BA, Peterson KE.

PLoS One. 2018 Jun 7;13(6):e0198612. doi: 10.1371/journal.pone.0198612. eCollection 2018.

29.

A Method to Summarize Toxicity in Cancer Randomized Clinical Trials.

Carbini M, Suárez-Fariñas M, Maki RG.

Clin Cancer Res. 2018 Oct 15;24(20):4968-4975. doi: 10.1158/1078-0432.CCR-17-3314. Epub 2018 May 8.

PMID:
29739789
30.

Ancylostoma ceylanicum, novel etiological agent for traveler's diarrhea-report of four Japanese patients who returned from Southeast Asia and Papua New Guinea.

Yoshikawa M, Ouji Y, Hirai N, Nakamura-Uchiyama F, Yamada M, Arizono N, Akamatsu N, Yoh T, Kaya D, Nakatani T, Kikuchi E, Katanami Y, Satoh K, Maki R, Miyazato Y, Oba Y, Kasahara K, Mikasa K.

Trop Med Health. 2018 Mar 13;46:6. doi: 10.1186/s41182-018-0087-8. eCollection 2018.

31.

Myeloperoxidase-catalyzed oxidation of cyanide to cyanate: A potential carbamylation route involved in the formation of atherosclerotic plaques?

Delporte C, Zouaoui Boudjeltia K, Furtmüller PG, Maki RA, Dieu M, Noyon C, Soudi M, Dufour D, Coremans C, Nuyens V, Reye F, Rousseau A, Raes M, Moguilevsky N, Vanhaeverbeek M, Ducobu J, Nève J, Robaye B, Vanhamme L, Reynolds WF, Obinger C, Van Antwerpen P.

J Biol Chem. 2018 Apr 27;293(17):6374-6386. doi: 10.1074/jbc.M117.801076. Epub 2018 Mar 1.

32.

Truncus Superior Artery Ventral to the Apical Vein of the Right Upper Lobe.

Maki R, Miyajima M, Mishina T, Watanabe A.

Ann Thorac Surg. 2018 Jul;106(1):e39. doi: 10.1016/j.athoracsur.2018.01.049. Epub 2018 Feb 23. No abstract available.

PMID:
29481788
33.

Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.

Heymach J, Krilov L, Alberg A, Baxter N, Chang SM, Corcoran RB, Dale W, DeMichele A, Magid Diefenbach CS, Dreicer R, Epstein AS, Gillison ML, Graham DL, Jones J, Ko AH, Lopez AM, Maki RG, Rodriguez-Galindo C, Schilsky RL, Sznol M, Westin SN, Burstein H.

J Clin Oncol. 2018 Apr 1;36(10):1020-1044. doi: 10.1200/JCO.2017.77.0446. Epub 2018 Jan 30.

PMID:
29380678
34.

Sarcoma: The Merging of Science and Clinical Care.

Schwartz GK, Maki RG.

J Clin Oncol. 2018 Jan 10;36(2):99-100. doi: 10.1200/JCO.2017.76.9091. Epub 2017 Dec 8. Review. No abstract available.

PMID:
29220300
35.

Carcinosarcomas and Related Cancers: Tumors Caught in the Act of Epithelial-Mesenchymal Transition.

Pang A, Carbini M, Moreira AL, Maki RG.

J Clin Oncol. 2018 Jan 10;36(2):210-216. doi: 10.1200/JCO.2017.74.9523. Epub 2017 Dec 8. Review.

PMID:
29220296
36.

Pathologic Angiogenesis of Malignant Vascular Sarcomas: Implications for Treatment.

Khan JA, Maki RG, Ravi V.

J Clin Oncol. 2018 Jan 10;36(2):194-201. doi: 10.1200/JCO.2017.74.9812. Epub 2017 Dec 8. Review.

PMID:
29220293
37.

Therapeutic effect of lyophilized, Kefir-fermented milk on constipation among persons with mental and physical disabilities.

Maki R, Matsukawa M, Matsuduka A, Hashinaga M, Anai H, Yamaoka Y, Hanada K, Fujii C.

Jpn J Nurs Sci. 2018 Jul;15(3):218-225. doi: 10.1111/jjns.12189. Epub 2017 Nov 6.

PMID:
29105976
38.

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial.

Tawbi HA, Burgess M, Bolejack V, Van Tine BA, Schuetze SM, Hu J, D'Angelo S, Attia S, Riedel RF, Priebat DA, Movva S, Davis LE, Okuno SH, Reed DR, Crowley J, Butterfield LH, Salazar R, Rodriguez-Canales J, Lazar AJ, Wistuba II, Baker LH, Maki RG, Reinke D, Patel S.

Lancet Oncol. 2017 Nov;18(11):1493-1501. doi: 10.1016/S1470-2045(17)30624-1. Epub 2017 Oct 4. Erratum in: Lancet Oncol. 2017 Dec;18(12 ):e711. Erratum in: Lancet Oncol. 2018 Jan;19(1):e8.

PMID:
28988646
39.

Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors.

Izumchenko E, Paz K, Ciznadija D, Sloma I, Katz A, Vasquez-Dunddel D, Ben-Zvi I, Stebbing J, McGuire W, Harris W, Maki R, Gaya A, Bedi A, Zacharoulis S, Ravi R, Wexler LH, Hoque MO, Rodriguez-Galindo C, Pass H, Peled N, Davies A, Morris R, Hidalgo M, Sidransky D.

Ann Oncol. 2017 Oct 1;28(10):2595-2605. doi: 10.1093/annonc/mdx416.

40.

Activity of Eribulin in Patients With Advanced Liposarcoma Demonstrated in a Subgroup Analysis From a Randomized Phase III Study of Eribulin Versus Dacarbazine.

Demetri GD, Schöffski P, Grignani G, Blay JY, Maki RG, Van Tine BA, Alcindor T, Jones RL, D'Adamo DR, Guo M, Chawla S.

J Clin Oncol. 2017 Oct 20;35(30):3433-3439. doi: 10.1200/JCO.2016.71.6605. Epub 2017 Aug 30. Erratum in: J Clin Oncol. 2018 Feb 1;36(4):432.

PMID:
28854066
41.

Vacuum Referred Binding Energy (VRBE)-Guided Design of Orange Persistent Ca3Si2O7:Eu2+ Phosphors.

Ueda J, Maki R, Tanabe S.

Inorg Chem. 2017 Sep 5;56(17):10353-10360. doi: 10.1021/acs.inorgchem.7b01214. Epub 2017 Aug 23.

PMID:
28832131
42.

Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.

Stacchiotti S, Mir O, Le Cesne A, Vincenzi B, Fedenko A, Maki RG, Somaiah N, Patel S, Brahmi M, Blay JY, Boye K, Sundby Hall K, Gelderblom H, Hindi N, Martin-Broto J, Kosela H, Rutkowski P, Italiano A, Duffaud F, Kobayashi E, Casali PG, Provenzano S, Kawai A.

Oncologist. 2018 Jan;23(1):62-70. doi: 10.1634/theoncologist.2017-0161. Epub 2017 Jul 28.

43.

Risk assessment in solitary fibrous tumors: validation and refinement of a risk stratification model.

Demicco EG, Wagner MJ, Maki RG, Gupta V, Iofin I, Lazar AJ, Wang WL.

Mod Pathol. 2017 Oct;30(10):1433-1442. doi: 10.1038/modpathol.2017.54. Epub 2017 Jul 21.

44.

Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial.

Hensley ML, Patel SR, von Mehren M, Ganjoo K, Jones RL, Staddon A, Rushing D, Milhem M, Monk B, Wang G, McCarthy S, Knoblauch RE, Parekh TV, Maki RG, Demetri GD.

Gynecol Oncol. 2017 Sep;146(3):531-537. doi: 10.1016/j.ygyno.2017.06.018. Epub 2017 Jun 24.

45.

Targeting sarcoma tumor-initiating cells through differentiation therapy.

Han D, Rodriguez-Bravo V, Charytonowicz E, Demicco E, Domingo-Domenech J, Maki RG, Cordon-Cardo C.

Stem Cell Res. 2017 May;21:117-123. doi: 10.1016/j.scr.2017.04.004. Epub 2017 Apr 13.

46.

Video-assisted thoracoscopic surgery node dissection for lung cancer treatment.

Watanabe A, Miyajima M, Mishina T, Tsuruta K, Takahashi Y, Maki R, Tada M.

Surg Today. 2017 Dec;47(12):1419-1428. doi: 10.1007/s00595-017-1494-x. Epub 2017 Mar 11. Review.

PMID:
28285463
47.

Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033.

Heinrich MC, Rankin C, Blanke CD, Demetri GD, Borden EC, Ryan CW, von Mehren M, Blackstein ME, Priebat DA, Tap WD, Maki RG, Corless CL, Fletcher JA, Owzar K, Crowley JJ, Benjamin RS, Baker LH.

JAMA Oncol. 2017 Jul 1;3(7):944-952. doi: 10.1001/jamaoncol.2016.6728. Erratum in: JAMA Oncol. 2017 Jul 1;3(7):1002.

48.

Treatment of soft tissue sarcoma: a focus on earlier stages.

Gronchi A, Maki RG, Jones RL.

Future Oncol. 2017 Jan;13(1s):13-21. Review.

PMID:
27918202
49.

PICASSO III: A Phase III, Placebo-Controlled Study of Doxorubicin With or Without Palifosfamide in Patients With Metastatic Soft Tissue Sarcoma.

Ryan CW, Merimsky O, Agulnik M, Blay JY, Schuetze SM, Van Tine BA, Jones RL, Elias AD, Choy E, Alcindor T, Keedy VL, Reed DR, Taub RN, Italiano A, Garcia Del Muro X, Judson IR, Buck JY, Lebel F, Lewis JJ, Maki RG, Schöffski P.

J Clin Oncol. 2016 Nov 10;34(32):3898-3905. doi: 10.1200/JCO.2016.67.6684. Epub 2016 Sep 30.

PMID:
27621408
50.

Knowns and Known Unknowns of Gastrointestinal Stromal Tumor Adjuvant Therapy.

Martínez-Marín V, Maki RG.

Gastroenterol Clin North Am. 2016 Sep;45(3):477-86. doi: 10.1016/j.gtc.2016.04.006. Review.

PMID:
27546844

Supplemental Content

Support Center